insights into a novel antibody-drug conjugate in myeloma: hdp-101
Published 1 year ago • 60 plays • Length 0:57Download video MP4
Download video MP3
Similar videos
-
2:25
novel ai model for personalized risk stratification & treatment in newly diagnosed multiple myeloma
-
1:26
advances in drug development in myeloma treatment
-
2:56
novel drugs for myeloma thromboprophylaxis
-
1:53
the future of multiple myeloma treatment
-
2:22
the benefit of autologous transplantation in the era of novel agents in multiple myeloma
-
1:26
insight-mm study update: treatment patterns in first and second-line multiple myeloma
-
4:18
novel drugs in the r/r mm: imids
-
1:02
novel agents in multiple myeloma: considering toxicity and side effects
-
4:27
antibody-based targeting of bcma in multiple myeloma
-
0:54
azintuxizumab vedotin for r/r multiple myeloma
-
3:41
emerging therapies for r/r myeloma
-
2:20
ultra high-risk myeloma
-
1:17
novel agents to improve outcomes for patients with multiple myeloma in the salvage setting
-
3:12
balancing efficacy and tolerability in multiple myeloma
-
2:25
new insight into the biology of multiple myeloma: from clonal evolution to new treatment options
-
2:22
immuno-oncology and the future of multiple myeloma treatment
-
2:02
rwd from insight-mm: duration of therapy and treatment sequencing